Company Overview - Mobile-health Network Solutions (MNDR) is a leading AI-powered digital healthcare platform provider headquartered in Singapore, with operations across Southeast Asia and plans to expand into the US [5] - The company offers telemedicine, AI-driven health tools, and virtual clinic infrastructure aimed at making healthcare accessible and intelligent through technology [5] Reverse Stock Split Announcement - MNDR announced a one-for-five reverse stock split effective at 12:01 a.m. Eastern Time on September 25, 2025, reducing the number of outstanding shares from approximately 4,684,779 to about 936,956 [1][2] - The number of authorized shares will decrease from 781,250,000 to 156,250,000, and the par value per share will change from $0.000032 to $0.00016 [2] Shareholder Communication and Process - VStock Transfer, LLC will act as the transfer agent, notifying stockholders of record and issuing post-split shares in paperless "book-entry" form [3] - Shareholders with certificated shares will receive instructions on how to surrender their certificates, while those holding shares in "street name" will have their positions automatically adjusted [3] Strategic Implications - The completion of the reverse stock split is seen as a significant advantage for MNDR in retaining its Nasdaq listing, which aligns with the company's strategic objectives [5]

Company Overview - Innovation Beverage Group Ltd (IBG) is an innovative developer, manufacturer, and marketer of a beverage portfolio consisting of 60 formulations across 13 alcoholic and non-alcoholic brands [5] - The company focuses on premium and super premium brands, aiming to disrupt established market leaders, with its most successful brand being Australian Bitters [5] - IBG was established in 2018 and is headquartered in Sydney, Australia, with a U.S. sales office in California [5] Reverse Stock Split Announcement - IBG announced a five-for-one reverse stock split of its ordinary shares, effective at 12:01 a.m. Eastern Time on September 26, 2025 [2] - Following the reverse stock split, the number of ordinary shares will decrease from 11,613,489 to 2,322,698 [2] Nasdaq Compliance Issues - On August 29, 2025, IBG received a Nasdaq Staff Delisting Determination Letter indicating non-compliance with Nasdaq Listing Rule 5550(a)(2) [3] - The company has requested a hearing before the Nasdaq Hearings Panel, which is scheduled for October 2025, and this request has stayed any suspension or delisting actions pending the hearing outcome [3]

Core Viewpoint - ECD Automotive Design, Inc. has received approval from the Nasdaq Hearings Panel to continue its listing on Nasdaq, contingent upon meeting specific conditions related to minimum bid price and equity standards [1][5]. Group 1: Company Overview - ECD is recognized as the world's largest Land Rover and Jaguar restoration company, specializing in custom luxury builds, including bespoke Defenders, Range Rovers, Jaguar E-Types, Ford Mustangs, and Toyota FJs [1][3]. - The company was founded in 2013 by three British automotive enthusiasts and operates from a 100,000-square-foot facility in Kissimmee, Florida, employing 102 staff, including 67 craftsmen and technicians with a total of 66 ASE certifications [3]. Group 2: Financial Actions and Compliance - To comply with the $1.00 minimum bid price requirement, ECD executed a 1-for-40 reverse stock split of its common stock on September 18, 2025 [2]. - In June 2025, ECD secured a $500 million equity line of credit and a lender converted $15.5 million in debt to preferred equity, along with an additional purchase of $1.1 million in preferred stock [2]. - The company aims to demonstrate compliance with the minimum bid price by achieving a closing bid price of $1.00 or more for ten consecutive trading days by October 1, 2025, and to meet the equity standard of at least $2.5 million by January 7, 2026 [5]. Group 3: Management Commentary - Scott Wallace, CEO and Co-Founder of ECD, expressed satisfaction with the Panel's decision, highlighting the company's recent financial results, which show record quarterly revenue and an expanded product offering [1].

Core Viewpoint - N2OFF, Inc. has announced a one-for-thirty-five reverse stock split to enhance its stock price and attract institutional investors, effective September 22, 2025 [1][2]. Group 1: Reverse Stock Split Details - The reverse stock split will convert every 35 shares of outstanding common stock into one share, adjusting the per share exercise price and the number of shares for all outstanding options and warrants accordingly [2]. - The number of outstanding shares will decrease from approximately 33 million to about 953 thousand, while the number of authorized shares will remain unchanged [3]. - Stockholders will not receive fractional shares; instead, they will receive an additional fraction of a share to round up to the next whole share [3]. Group 2: Stockholder Actions - Registered stockholders holding shares in book-entry or through a bank or broker do not need to take any action regarding the reverse stock split [4]. - Stockholders with physical stock certificates will receive instructions from the Company's transfer agent for exchanging their certificates for new ones reflecting the post-split number of shares [4]. Group 3: Company Overview - N2OFF, Inc. is focused on sustainable solutions in the energy and agri-tech sectors, including integrated solutions for sustainable energy and greenhouse gas emissions reduction [6]. - The company is a lead investor in four solar projects across three EU countries and has a majority-owned subsidiary, Save Foods Ltd., which specializes in post-harvest treatments for fruits and vegetables [6].

Core Viewpoint - Bollinger Innovations, Inc. will implement a 1-for-250 reverse stock split to comply with Nasdaq's minimum bid price requirement of $1.00, effective September 22, 2025 [2][3][4] Group 1: Reverse Stock Split Details - The reverse stock split will convert 250 shares of common stock into one share, resulting in approximately 505 thousand shares post-split, down from approximately 126.2 million shares [5] - The reverse stock split will not change the par value of the common stock or the authorized number of shares [4] - No fractional shares will be issued; all fractional shares will be rounded up to the nearest whole share [5] Group 2: Compliance and Approval - The reverse stock split was approved by the stockholders at a special meeting on September 11, 2025, with the board of directors selecting the 1-for-250 ratio [3] - The primary goal of the reverse stock split is to ensure compliance with Nasdaq's listing standards, although there is no guarantee that the company will maintain compliance [2] Group 3: Company Overview - Bollinger Innovations is an electric vehicle manufacturer based in Southern California, focusing on commercial electric vehicles with a manufacturing facility in Tunica, Mississippi [7] - The company offers the ONE Class 1 EV cargo van and the THREE Class 3 EV cab chassis truck, supported by a dealer network across key U.S. markets [7]

Core Points - ECD Automotive Design, Inc. will implement a 1-for-40 reverse stock split effective September 18, 2025, to increase its stock price above the $1.00 minimum bid requirement for Nasdaq listing [1][2] - The reverse stock split will reduce the number of outstanding shares from approximately 59,091,136 to about 1,477,278 shares, without changing the number of authorized shares or par value [3] - Shareholders holding shares electronically will not need to take action, while those with certificated shares will receive instructions from the transfer agent [4] Company Overview - ECD is the world's largest Land Rover and Jaguar restoration company, known for custom luxury builds including bespoke Defenders, Range Rovers, and Jaguar E-Types [1][6] - Founded in 2013, ECD combines classic vehicle aesthetics with modern performance, employing 102 staff, including 67 craftsmen with numerous certifications [6] - The company operates from a 100,000-square-foot facility in Kissimmee, Florida, and has a logistics center in the U.K. for sourcing restoration vehicles [6]

Core Points - Athira Pharma, Inc. is a clinical-stage biopharmaceutical company focused on therapies for neurodegenerative diseases [1] - A reverse stock split will occur on September 18, 2025, consolidating shares at a ratio of 1-for-10, approved by stockholders [1][2] - The reverse stock split aims to enhance the stock's marketability and potentially attract more investors [1][4] Stock Performance - Currently, ATHA's stock is priced at $0.38, with a slight increase of 0.29% or $0.0011 [3] - The stock has shown volatility, with a low of $0.35 and a high of $0.40 on the current trading day [3] - Over the past year, ATHA's stock has fluctuated between a high of $0.83 and a low of $0.22 [3] Market Capitalization and Trading Volume - Athira Pharma's market capitalization is approximately $15.1 million [4] - The trading volume on the NASDAQ exchange is 586,605 shares [4] - The reverse stock split may reduce the number of shares outstanding, potentially increasing the stock price [4]

Core Viewpoint - Biodesix, Inc. announced a one-for-twenty reverse stock split effective September 15, 2025, aimed at reducing the number of outstanding shares and potentially improving the stock's market perception [1][2]. Group 1: Reverse Stock Split Details - The reverse stock split was approved by stockholders on May 20, 2025, with the final ratio determined by the board of directors [2]. - The number of shares will decrease from approximately 156 million to about 8 million, with adjustments for fractional shares [2]. - The reverse stock split will not change stockholders' percentage ownership interests, except for fractional shares, which will be compensated in cash [3]. Group 2: Impact on Equity Incentive Plans - The number of shares available under the Company's equity incentive plans and the exercise prices of outstanding options and warrants will be proportionately adjusted [4]. Group 3: Administrative Process - Computershare Trust Company, N.A. will act as the transfer agent, managing the transition to post-split shares without requiring action from registered stockholders [5]. - Stockholders with certificated shares will receive instructions from Computershare on how to surrender their pre-split shares [5]. Group 4: Company Overview - Biodesix is a leader in personalized diagnostics, focusing on improving clinical care and outcomes for patients, particularly in lung disease [7].

A stock split -- one way or the other -- artificially changes a company's stock price and outstanding share count.The electric vehicle (EV) maker Lucid Group (LCID 13.92%) recently executed a 1-for-10 reverse stock split, which will artificially increase its share price and decrease its outstanding share count while keeping the company's market cap unchanged.Stock splits are typically conducted for a specific reason and usually after a big move for a stock. Prior to the reverse split, shares of Lucid were d ...

Core Viewpoint - Lucid's stock is experiencing a significant decline following a reverse stock split, raising concerns about the company's stability and future performance [1][2][4]. Group 1: Stock Performance - Lucid shares fell 7.5% on Thursday, marking a three-day decline after the reverse stock split [1]. - The stock has dropped nearly 20% since the opening of trading on Tuesday, despite the overall market gaining [2][4]. Group 2: Reverse Stock Split - The reverse stock split reduced the number of shares held by shareholders to 10% of the previous amount, with each share now valued at ten times more [2]. - Reverse splits are generally perceived negatively by the market, often indicating financial trouble for the company [2]. - The split was intended to make Lucid's stock more appealing to institutional investors, who typically have minimum share value requirements [4]. Group 3: Company Outlook - There are doubts about Lucid's ability to execute a necessary turnaround, leading to skepticism about the stock's future performance [5].